About this trial

Patient Profile

Any solid Tumour with a Somatic HER2 or EGFR Exon 18 Mutation

Where’s this trial being run?

Cork University Hospital, St Vincents University Hospital, University Hospital Waterford, and Mater Misericordiae University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Number: CTRIAL-IE 19-22
Full Title:

An Open-label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification (SUMMIT)

Principal Investigator: John Crown
Type: Industry Sponsored

Puma Biotechnology Inc.

Recruitment Started: Global:
Global Recruitment Target:
Ireland Recruitment Target: